Your browser doesn't support javascript.
loading
Mitochondrial RNA methyltransferase TRMT61B is a new, potential biomarker and therapeutic target for highly aneuploid cancers.
Martín, Alberto; Epifano, Carolina; Vilaplana-Marti, Borja; Hernández, Iván; Macías, Rocío I R; Martínez-Ramírez, Ángel; Cerezo, Ana; Cabezas-Sainz, Pablo; Garranzo-Asensio, Maria; Amarilla-Quintana, Sandra; Gómez-Domínguez, Déborah; Caleiras, Eduardo; Camps, Jordi; Gómez-López, Gonzalo; Gómez de Cedrón, Marta; Ramírez de Molina, Ana; Barderas, Rodrigo; Sánchez, Laura; Velasco-Miguel, Susana; Pérez de Castro, Ignacio.
Afiliação
  • Martín A; Gene Therapy Unit, Instituto de Investigación de Enfermedades Raras, Instituto de Salud Carlos III (ISCIII), Madrid, Spain. martin.alberto77@gmail.com.
  • Epifano C; Gene Therapy Unit, Instituto de Investigación de Enfermedades Raras, Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
  • Vilaplana-Marti B; Gene Therapy Unit, Instituto de Investigación de Enfermedades Raras, Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
  • Hernández I; Gene Therapy Unit, Instituto de Investigación de Enfermedades Raras, Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
  • Macías RIR; Experimental Hepatology and Drug Targeting (HEVEPHARM) Group, University of Salamanca, Biomedical Research Institute of Salamanca (IBSAL), Salamanca, Spain.
  • Martínez-Ramírez Á; National Institute for the Study of Liver and Gastrointestinal Diseases, CIBERehd, Carlos III Health Institute, Madrid, Spain.
  • Cerezo A; Department of Molecular Cytogenetics, MD Anderson Cancer Center, Madrid, Spain.
  • Cabezas-Sainz P; Oncohematology Cytogenetics Laboratory, Eurofins-Megalab, Madrid, Spain.
  • Garranzo-Asensio M; Lilly Cell Signaling and Immunometabolism Section, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
  • Amarilla-Quintana S; Department of Zoology, Genetics and Physical Anthropology, Universidade de Santiago de Compostela, Campus de Lugo, 27002, Lugo, Spain.
  • Gómez-Domínguez D; Chronic Disease Program (UFIEC), Instituto de Salud Carlos III (ISCIII), E-28220, Madrid, Spain.
  • Caleiras E; Gene Therapy Unit, Instituto de Investigación de Enfermedades Raras, Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
  • Camps J; Programa de Doctorado UNED-ISCIII Ciencias Biomédicas y Salud Pública, Universidad Nacional de Educación a Distancia (UNED), Madrid, Spain.
  • Gómez-López G; Gene Therapy Unit, Instituto de Investigación de Enfermedades Raras, Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
  • Gómez de Cedrón M; Histopathology Core Unit, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
  • Ramírez de Molina A; Unitat de Recerca Biomèdica, Hospital Universitari de Sant Joan, Institut d'Investigacio´ Sanitària Pere Virgili, Universitat Rovira i Virgili, Reus, Spain.
  • Barderas R; Bioinformatics Unit, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
  • Sánchez L; Molecular Oncology Group, Precision Nutrition and Cancer Program, IMDEA FOOD, CEI UAM+CSIC, Madrid, Spain.
  • Velasco-Miguel S; Molecular Oncology Group, Precision Nutrition and Cancer Program, IMDEA FOOD, CEI UAM+CSIC, Madrid, Spain.
  • Pérez de Castro I; Chronic Disease Program (UFIEC), Instituto de Salud Carlos III (ISCIII), E-28220, Madrid, Spain.
Cell Death Differ ; 30(1): 37-53, 2023 01.
Article em En | MEDLINE | ID: mdl-35869285
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Metiltransferases / Neoplasias Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Metiltransferases / Neoplasias Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article